Plunkett’s Industry Almanacs in Printed and eBook Formats

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry.Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

• Business trends analysis
• In-depth industry overview
• Technology trends analysis
• Forecasts
• Spending, investment, and consumption discussions
• In-depth industry statistics and metrics
• Industry employment numbers

Additional Key Features Include:

Industry Glossary

Industry Contacts list, including Professional Societies and Industry Associations

Profiles of industry-leading companies

• Business trends analysis
• In-depth industry overview
• Technology trends analysis
• Forecasts
• Spending, investment, and consumption discussions
• In-depth industry statistics and metrics
• Industry employment numbers

Key Questions Answered Include:

• How is the industry evolving?
• How is the industry being shaped by new technologies?
• How is demand growing in emerging markets and mature economies?
• What is the size of the market now and in the future?
• What are the financial results of the leading companies?
• What are the names and titles of top executives?
• What are the top companies and what are their revenues?
  
  

This feature-rich report covers competitive intelligence, market research and business analysis—everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.

Plunkett Research Provides Unique Analysis of the Following Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

1. The State of the Biotechnology Industry Today

2. A Short History of Biotechnology

3. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation

4. Ethanol Production Soared, But U.S. Federal Subsidy Expired

5. Cellulosic Ethanol Makes Slow Commercial Progress

6. Major Drug Companies Acquire or Partner With Smaller Biotech Firms

7. Pharmaceutical R&D Improves with Artificial Intelligence (AI)

8. Nations Compete Fiercely in Biotech Development

9. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance

10. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing

11. Vaccines & Viruses as Therapies/mRNA Shows Great Promise

12. Massive R&D Investment Required for Development and Approval of New Drugs/ Drug Prices Soar

13. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues

14. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare

15. Biotech and Orphan Drugs Create New Revenues for Drug Firms

16. Revolutionary New Drugs (Zepbound, Ozempic and Wegovy) Treat Obesity, Diabetes and Addiction/Show Promise for Treating Many Other Diseases

17. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce

18. Market for CBD Remains Steady

19. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape

20. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High

21. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation

22. Plant-Based Meat Substitutes Developed

23. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds

24. Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers

25. Technology Discussion—Genes and DNA

26. Technology Discussion—Proteins and Proteomics

27. Technology Discussion—DNA Chips

28. Technology Discussion—SNPs (“Snips”)

29. Technology Discussion—Synthetic Biology

30. Technology Discussion—Recombinant DNA

31. Technology Discussion—Polymerase Chain Reaction (PCR)

Plunkett Research Provides In-Depth Tables for the Following Biotech, Pharmaceuticals & Genetics Industry Statistics

1. Biotech IndustryStatistics and Market Size Overview

2. The U.S. Drug Discovery & Approval Process

3. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2023

4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2023

5. Federal R&D & R&D Funding for Basic Research, U.S.: Fiscal Years 2022-2024

6. U.S. Exports & Imports of Pharmaceutical Products: 2018-2023

7. Prescription Drug Expenditures, U.S.: Selected Years, 2015-2031

8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years: 2023-2025

9. Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2022-2024